The genotypic distribution of drug resistant Mycobacterium tuberculosis strains isolated from Northern region of Myanmar

Main Article Content

Waing Waing Moe Sann
Thyn Lei Swe
Kyi Kyi Swe
Thandar Thwin
Arunnee Sangka

Abstract

Myanmar is one of both 30 high TB and MDR-TB burden countries worldwide. While most studies have expressed distribution of Mycobacterium tuberculosis genotypes in Lower Myanmar, there has been little research in genetic diversity of M. tuberculosis in Northern region. The objective of this study was to determine the genotypic distribution of drug resistant M. tuberculosis strains isolated from Northern region of Myanmar. Sixty-fve isolates were randomly collected from TB Reference Laboratory of Northern region of Myanmar between August 2016 and December 2017. All isolates were genotyped by using 24-locus Mycobacterial Interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing. The results
showed MIRU-VNTR typing classifed 64 different patterns: 63 isolates had unique MIRU-VNTR profle and 2 isolates were grouped into one cluster. We found that the most prominent strains were Beijing lineages (n = 58, 89.23%) and the other included EAI (n = 2, 3.08%), Delhi/CAS (n = 1, 1.54%), and Unknown strains (n = 4, 6.15%). The overall discriminatory power of all strains showed 0.9995. The allelic diversity of each locus was predictable by HGDI index. Mtub21, Qub2163b, MIRU 26, QUB26 showed HGDI > 0.6 that were recognized as highly discriminatory power. In conclusion, 24-locus MIRU-VNTR offered high discriminatory power within tested isolates. Our fndings showed Beijing genotypes were dominant in Northern region of Myanmar. The analysis of 24-locus MIRU-VNTR typing might be useful for broader understanding of TB outbreaks and epidemiology in this region. 

Article Details

How to Cite
1.
Moe Sann WW, Swe TL, Swe KK, Thwin T, Sangka A. The genotypic distribution of drug resistant Mycobacterium tuberculosis strains isolated from Northern region of Myanmar. Arch AHS [Internet]. 2021 Apr. 23 [cited 2024 Mar. 19];33(1):34-43. Available from: https://he01.tci-thaijo.org/index.php/ams/article/view/243112
Section
Original article

References

Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003; 16: 463-96.

World Health Organization. Global tuberculosis report 2016. WHO /HTM /TB /2016. Geneva, Switzerland: WHO, 2016.

World Health Organization. Global Tuberculsis Report 2017. WHO /HTM /TB /2017. Geneva, Switzerland: WHO, 2017.

Tuberculosis in Myanmar Progress, Plans and Challenges. 2015.

World Health Organization. Global Tuberculosis Report 2014. WHO /HTM /TB /2014. Geneva, Switzerland: WHO, 2014.

Narayanan S. Molecular epidemiology of tuberculosis. Indian J Med Res 2004; 120: 233-47.

Mostroin P, Cordon M, Sola C, Ridele M, Rastogp N. Methods used in the molecular epidemiology of tuberculosis. Clin Microbiol Infect 2002; 8: 694-704.

Rozo-anaya JC. Molecular tools for Mycobacterium tuberculosis genotyping. Revisita De Salud Publica 2010; 12: 510-21.

Maes M, Kremer K, Van Soolingen D, Takiff H, Waard JH. 24-Locus MIRU-VNTR genotyping is a useful tool to study the molecular epidemiology of tuberculosis among Warao Amerindians in Venezuela. Tuberculosis 2008; 88: 490-4.

Supply P. Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit – Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosi. J Clin Microbiol 2006; 44: 4498-510.

Dong H. Genetic diversity of Mycobacterium tuberculosis isolates from Tibetans in Tibet, China. PLoS One 2012; 7: 1-7.

Amaro A, Duarte E, Amado A, Ferronha H, Botelho A. Comparison of three DNA extraction methods for Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium subsp. avium. Soc Appl Microbiol 2008; 47: 8-11.

Stinson KW, Eisenach K, Kayes S, Matsumoto M, Siddiqi S, Nakashima S. Mycobacteriology Laboratory Manual. 5th ed. CDC; 2014.

Supply P. Multilocus Variable Number Tandem Repeat Genotyping of Mycobacterium tuberculosis technical guide. Lille, France: National Institute of Health and Medical Research Unit 629 Institute of Biology/asteur Institute of Lille, 2005.

Hunter P. Reproducibility and indices of discriminatory power of microbial typing methods. J Clin Microbiol 1990; 28: 1903-5.

Shemko M, Yates M, Fang Z, Gibson A, Shetty N. Molecular epidemiology of Mycobacterium tuberculosis in patients of Somalian and white ethnic origin attending an inner London clinic. Int J Tuberc Lung Dis 2004; 8: 186-93.

Augusto CJ. Comparative study of RFLP-IS6110 and MIRU-VNTR from Mycobacterium tuberculosis isolated in the state of Minas Gerais, Brazil. Brazilian J Microbiol 2018; 334: 6-11.

Sola C. Genotyping of the Mycobacterium tuberculosis complex using MIRUs: Association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect Genet Evol 2003; 3: 125-33.

Pan X. A quantitative and effcient approach to select MIRU -VNTR loci based on accumulation of the percentage differences of strains for discriminating divergent Mycobacterium tuberculosis sublineages. Emerginh Microbes Infect 2017; 1-8.

Liu Y. Genotypic diversity analysis of Mycobacterium tuberculosis strains collected from Beijing in 2009, using spoligotyping and VNTR typing. PLoS One 2014; 9(9): e106787.

Van SD. Predominnance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33: 3234-8.

Phyu S. Predominance of Mycobacterium tuberculosis EAI and Beijing Lineages in Yangon, Myanmar J Clin Microbiol 2009; 47: 335-44.

Brudey K. Mycobacterium tuberculosis complex genetic diversity: Mining the fourth international poligotyping database (SpolDB4) for classifcation, population genetics and epidemiology. BMC Microbiol 2006; 6: 1-17.

Manca C. Differential Monocyte Activation Underlies Strain-Specifc Mycobacterium tuberculosis pathogenesis differential monocyte activation underlies strain-specific mycobacterium tuberculosis pathogenesis. Infect Immun 2004; 72: 5511-4.

Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: A systematic review. Emerg Infect Dis 2002; 8: 843-9.

Tun T. Genotypic diversity of Mycobacterium tuberculosis strains in Myanmar. Infect Dis(Auckl) 2017; 49: 237-9.

Ei PW, Aung WW, Nyunt WW, Swe TL, Htwe MM, Win SM, et al. Extensively drug- resistant tuberculosis in Myanmar: burden and mutations causing second- line drug resistance. Int J Tuberc lung Dis 2018; 22: 47-53.

Devi KR. Genetic diversity of Mycobacterium tuberculosis isolates from Assam, India: Dominance of beijing family and discovery of two new clades related to CAS1-Delhi and EAI family based on spoligotyping and MIRU-VNTR typing. PLoS One 2015;10: 1-20.

Liu HC. Molecular Typing Characteristic and Drug Susceptibility Analysis of Mycobacterium tuberculosis Isolates from Zigong, China. Biomed Res Int 2016; 1-7.

San LL, Aye KS, Oo NAT, Shwe MM, Fukushima Y, Gordon SV, et al. Insight into multidrug-resistant Beijing genotype Mycobacterium tuberculosis isolates in Myanmar. International Journal of Infectious Diseases 2018; 76: 109-19.

DeHaas PE, Khosravi AD, Feizabadi MM, Jolodar A. Study of genetic diversity in Mycobacterium tuberculosis by using mycobacterial interspersed repetitive unit: Variable number tandem repeat typing in African J Microbiol Res 2011; 5: 1549-56.

Iwamoto T. Genetic Diversity and Transmission Characteristics of Beijing Family Strains of Mycobacterium tuberculosis in Peru. PLoS One 2012; 7(11): e49651.

Hamblion EL, Le Menach A, Anderson LF, et al. Recent TB transmission, clustering and predictors of large clusters in London, 2010-2012: Results from first 3-years of universal MIRU-VNTR strain typing. Thorax 2016; 71(8):749-56.

Moonan PK, Ghosh S, Oeltmann JE, Kammerer JS, Cowan LS, Navin TR. Using genotyping and geospatial scanning to estimate recent Mycobacterium tuberculosis transmission, United States. Emerg Infect Dis 2012; 18(3): 458-65.

Xu G, Mao X, Wang J, Pan H. Clustering and recent transmission of Mycobacterium tuberculosis in a Chinese population. Infect Drug Resist 2018; 11: 323-30.